+39 02 610346.1 - info@newron.com

Ralfinamide

Ralfinamide

Newron is intending to develop ralfinamide, a novel well-tolerated small molecule for the treatment of neuropathic pain.

Ralfinamide is a unique New Chemical Entity that is believed to mediate its potent analgesic effect through the inhibition of sodium channels, including Nav 1.7, N-type Calcium channels and NMDA receptor.